Mirum Pharmaceuticals, Inc. MIRM Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s change in lease liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported change in lease liabilities of -$583K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s change in lease liabilities changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s change in lease liabilities decreased by 42.9% year-over-year, from -$408K to -$583K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s change in lease liabilities?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s change in lease liabilities has grown at a 30.7% compound annual growth rate (CAGR), from -$649K to -$1.9M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.